359 related articles for article (PubMed ID: 33816399)
1. Kawasaki Disease Shock Syndrome in Japan and Comparison With Multisystem Inflammatory Syndrome in Children in European countries.
Suzuki J; Abe K; Matsui T; Honda T; Yasukawa K; Takanashi JI; Hamada H
Front Pediatr; 2021; 9():625456. PubMed ID: 33816399
[TBL] [Abstract][Full Text] [Related]
2. Comparison of COVID-19-associated multisystem inflammatory syndrome in children (MIS-C) and Kawasaki disease shock syndrome: case reports and literature review.
Lee S; Kim D; Kim BJ; Rhim JW; Lee SY; Jeong DC
J Rheum Dis; 2023 Oct; 30(4):272-277. PubMed ID: 37736588
[TBL] [Abstract][Full Text] [Related]
3. Similarities and Differences between Multisystem Inflammatory Syndrome in Children (MIS-C) and Kawasaki Disease Shock Syndrome.
Lee J; Kim BJ; Cho KS; Rhim JW; Lee SY; Jeong DC
Children (Basel); 2023 Sep; 10(9):. PubMed ID: 37761488
[TBL] [Abstract][Full Text] [Related]
4. Kawasaki Disease Shock Syndrome vs Classical Kawasaki Disease: A Meta-analysis and Comparison With SARS-CoV-2 Multisystem Inflammatory Syndrome.
Lamrani L; Manlhiot C; Elias MD; Choueiter NF; Dionne A; Harahsheh AS; Portman MA; McCrindle BW; Dahdah N
Can J Cardiol; 2021 Oct; 37(10):1619-1628. PubMed ID: 34090979
[TBL] [Abstract][Full Text] [Related]
5. Phenotype, Susceptibility, Autoimmunity, and Immunotherapy Between Kawasaki Disease and Coronavirus Disease-19 Associated Multisystem Inflammatory Syndrome in Children.
Chen MR; Kuo HC; Lee YJ; Chi H; Li SC; Lee HC; Yang KD
Front Immunol; 2021; 12():632890. PubMed ID: 33732254
[TBL] [Abstract][Full Text] [Related]
6. Kawasaki disease shock syndrome: clinical characteristics and possible use of IL-6, IL-10 and IFN-γ as biomarkers for early recognition.
Li Y; Zheng Q; Zou L; Wu J; Guo L; Teng L; Zheng R; Jung LKL; Lu M
Pediatr Rheumatol Online J; 2019 Jan; 17(1):1. PubMed ID: 30611297
[TBL] [Abstract][Full Text] [Related]
7. Laboratory parameters between multisystem inflammatory syndrome in children and Kawasaki disease.
Zhou C; Zhao Y; Wang X; Huang Y; Tang X; Tang L
Pediatr Pulmonol; 2021 Dec; 56(12):3688-3698. PubMed ID: 34583417
[TBL] [Abstract][Full Text] [Related]
8. Clinical manifestations of Kawasaki disease shock syndrome: a case-control study.
Chen PS; Chi H; Huang FY; Peng CC; Chen MR; Chiu NC
J Microbiol Immunol Infect; 2015 Feb; 48(1):43-50. PubMed ID: 23927822
[TBL] [Abstract][Full Text] [Related]
9. Similarities and differences between multiple inflammatory syndrome in children associated with COVID-19 and Kawasaki disease: clinical presentations, diagnosis, and treatment.
Zhang QY; Xu BW; Du JB
World J Pediatr; 2021 Aug; 17(4):335-340. PubMed ID: 34013488
[TBL] [Abstract][Full Text] [Related]
10. Kawasaki disease shock syndrome: Unique and severe subtype of Kawasaki disease.
Gamez-Gonzalez LB; Moribe-Quintero I; Cisneros-Castolo M; Varela-Ortiz J; Muñoz-Ramírez M; Garrido-García M; Yamazaki-Nakashimada M
Pediatr Int; 2018 Sep; 60(9):781-790. PubMed ID: 29888440
[TBL] [Abstract][Full Text] [Related]
11. Kawasaki Disease Shock Syndrome in the Eastern Region of Saudi Arabia: Case Series.
Busaleh F; AlKadhem SM; Albarrak A; Almubarak AA; Aldandan MM; Almajed JM; Alabdullah MA; Almulaifi LF
Cureus; 2021 May; 13(5):e14961. PubMed ID: 34123658
[TBL] [Abstract][Full Text] [Related]
12. Kawasaki disease shock syndrome in the COVID-19 pandemic.
Gámez-González LB; Ramírez-López MJ; Colmenero-Rascón M; Yamazaki-Nakashimada MA
Cardiol Young; 2022 Mar; 32(3):506-507. PubMed ID: 34278987
[TBL] [Abstract][Full Text] [Related]
13. [Kawasaki disease and multisystem inflammatory syndrome in children. Differences, and similarities in a pediatric center in Mexico].
García-Domínguez M; Anaya-Enríquez N; Luque-Vega L; Canizales-Muñoz S; Flores R; Tostado-Morales E; Torres CG; Melchor V; Quibrera J; Velázqueaz-Ríos C; León-Ramírez ÁR; Carreón-Guerrero JM; Llausás-Magaña E
Rev Alerg Mex; 2023 Jun; 70(2):80-88. PubMed ID: 37566771
[TBL] [Abstract][Full Text] [Related]
14. Clinical Subphenotypes of Multisystem Inflammatory Syndrome in Children: An EHR-based cohort study from the RECOVER program.
Rao S; Jing N; Liu X; Lorman V; Maltenfort M; Schuchard J; Wu Q; Tong J; Razzaghi H; Mejias A; Lee GM; Pajor NM; Schulert GS; Thacker D; Jhaveri R; Christakis DA; Bailey LC; Forrest CB; Chen Y
medRxiv; 2022 Sep; ():. PubMed ID: 36203555
[TBL] [Abstract][Full Text] [Related]
15. Kawasaki Disease Shock Syndrome Presented with Giant Coronary Artery Dilatation - Presentation of Two Cases and a Literature Review.
Bejiqi R; Pajaziti N; Agushi S
Acta Inform Med; 2022 Sep; 30(3):253-256. PubMed ID: 36311151
[TBL] [Abstract][Full Text] [Related]
16. Characteristics of Kawasaki Disease Patients during the COVID-19 Pandemic in Japan: A Single-Center, Observational Study.
Shimizu S; Ayusawa M; Go H; Nakazaki K; Namiki H; Kasuga Y; Nishimura K; Kanezawa K; Morohashi T; Morioka I
Children (Basel); 2021 Oct; 8(10):. PubMed ID: 34682178
[TBL] [Abstract][Full Text] [Related]
17. Comparison of Characteristics and Outcomes of Multisystem Inflammatory Syndrome, Kawasaki Disease and Toxic Shock Syndrome in Children.
Klavina L; Smane L; Kivite-Urtane A; Vasilevska L; Davidsone Z; Smitins E; Gardovska D; Lubaua I; Roge I; Pucuka Z; Meiere A; Pavare J
Medicina (Kaunas); 2023 Mar; 59(3):. PubMed ID: 36984627
[No Abstract] [Full Text] [Related]
18. Severe manifestations of SARS-CoV-2 in children and adolescents: from COVID-19 pneumonia to multisystem inflammatory syndrome: a multicentre study in pediatric intensive care units in Spain.
García-Salido A; de Carlos Vicente JC; Belda Hofheinz S; Balcells Ramírez J; Slöcker Barrio M; Leóz Gordillo I; Hernández Yuste A; Guitart Pardellans C; Cuervas-Mons Tejedor M; Huidobro Labarga B; Vázquez Martínez JL; Gutiérrez Jimeno M; Oulego-Erróz I; Trastoy Quintela J; Medina Monzón C; Medina Ramos L; Holanda Peña MS; Gil-Antón J; Sorribes Ortí C; Flores González JC; Hernández Palomo RM; Sánchez Ganfornina I; Fernández Romero E; García-Besteiro M; López-Herce Cid J; González Cortés R;
Crit Care; 2020 Nov; 24(1):666. PubMed ID: 33243303
[TBL] [Abstract][Full Text] [Related]
19. Kawasaki Disease and Multisystem Inflammatory Syndrome in Children: Common Inflammatory Pathways of Two Distinct Diseases.
Noval Rivas M; Arditi M
Rheum Dis Clin North Am; 2023 Aug; 49(3):647-659. PubMed ID: 37331738
[TBL] [Abstract][Full Text] [Related]
20. Defining Kawasaki disease and pediatric inflammatory multisystem syndrome-temporally associated to SARS-CoV-2 infection during SARS-CoV-2 epidemic in Italy: results from a national, multicenter survey.
Cattalini M; Della Paolera S; Zunica F; Bracaglia C; Giangreco M; Verdoni L; Meini A; Sottile R; Caorsi R; Zuccotti G; Fabi M; Montin D; Meneghel A; Consolaro A; Dellepiane RM; Maggio MC; La Torre F; Marchesi A; Simonini G; Villani A; Cimaz R; Ravelli A; Taddio A;
Pediatr Rheumatol Online J; 2021 Mar; 19(1):29. PubMed ID: 33726806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
